Helping investors, management teams and other stakeholders successfully steer through M&A transactions and supporting them in the transition phase of the company to the next stage of its journey is always a unique experience and very rewarding.
Felix advises clients on mergers and acquisitions (M&A) in Lincoln International’s Frankfurt office in the firm’s Global Healthcare Group.
Felix takes a proactive, pragmatic and flexible approach to achieve the best possible results for his clients.
Felix brings many years of M&A experience to the role, having held positions most recently as an M&A advisor at EY as part of the Life Sciences, Chemicals and Healthcare sector teams and previously at Siemens where he focused on today’s Siemens Healthineers, the company’s healthcare engineering segment.
Felix holds a master’s degree in business administration and economics from Witten/Herdecke University.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)